- Home
- SAND vs TWST Comparison
SAND vs TWST Comparison
Compare SAND & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAND
- TWST
- Stock Information
- Founded
- SAND 2007
- TWST 2013
- Country
- SAND Canada
- TWST United States
- Employees
- SAND N/A
- TWST N/A
- Industry
- SAND
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SAND
- TWST Health Care
- Exchange
- SAND NYSE
- TWST Nasdaq
- Market Cap
- SAND 2.4B
- TWST 2.3B
- IPO Year
- SAND N/A
- TWST 2018
- Fundamental
- Price
- SAND $8.81
- TWST $30.82
- Analyst Decision
- SAND Buy
- TWST Buy
- Analyst Count
- SAND 4
- TWST 10
- Target Price
- SAND $9.13
- TWST $49.10
- AVG Volume (30 Days)
- SAND 6.2M
- TWST 1.1M
- Earning Date
- SAND 05-06-2025
- TWST 05-05-2025
- Dividend Yield
- SAND 0.65%
- TWST N/A
- EPS Growth
- SAND 32.83
- TWST N/A
- EPS
- SAND 0.10
- TWST N/A
- Revenue
- SAND $183,537,000.00
- TWST $347,680,000.00
- Revenue This Year
- SAND $16.62
- TWST $22.54
- Revenue Next Year
- SAND $8.98
- TWST $17.77
- P/E Ratio
- SAND $90.20
- TWST N/A
- Revenue Growth
- SAND 2.84
- TWST 25.30
- 52 Week Low
- SAND $4.92
- TWST $29.76
- 52 Week High
- SAND $8.82
- TWST $60.90
- Technical
- Relative Strength Index (RSI)
- SAND 63.60
- TWST 32.67
- Support Level
- SAND $8.32
- TWST $31.56
- Resistance Level
- SAND $8.91
- TWST $33.68
- Average True Range (ATR)
- SAND 0.29
- TWST 2.54
- MACD
- SAND -0.03
- TWST -0.70
- Stochastic Oscillator
- SAND 89.39
- TWST 0.88
About SAND SANDSTORM GOLD LIMITED
Sandstorm Gold Ltd provides financing to companies engaged in gold mining through the gold stream and royalty. Geographically, the company has operational footprints in North America, South & Central America, Africa, and Asia & Australia. The firm's royalties include Hod Maden, Santa Elena, Chapada, Platreef, Greenstone, and Cerro Moro.
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.